AU2003250529A1 - A FORMULATION AND A PROCESS FOR REDUCING THE DETERIORATION OF RBCs OF BLOOD DURING STORAGE WITH PARTICULAR REFERENCE TO DECREASE IN THE LEVEL OF 2,3 DIPHOSPHOGLYCERATE - Google Patents

A FORMULATION AND A PROCESS FOR REDUCING THE DETERIORATION OF RBCs OF BLOOD DURING STORAGE WITH PARTICULAR REFERENCE TO DECREASE IN THE LEVEL OF 2,3 DIPHOSPHOGLYCERATE

Info

Publication number
AU2003250529A1
AU2003250529A1 AU2003250529A AU2003250529A AU2003250529A1 AU 2003250529 A1 AU2003250529 A1 AU 2003250529A1 AU 2003250529 A AU2003250529 A AU 2003250529A AU 2003250529 A AU2003250529 A AU 2003250529A AU 2003250529 A1 AU2003250529 A1 AU 2003250529A1
Authority
AU
Australia
Prior art keywords
diphosphoglycerate
rbcs
deterioration
formulation
decrease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003250529A
Other languages
English (en)
Inventor
Balagopal Chandrasekhar
Achutha Kurup Parameswara
Arun Peethambaran
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
TERUMO PENPOL Ltd
Original Assignee
TERUMO PENPOL Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by TERUMO PENPOL Ltd filed Critical TERUMO PENPOL Ltd
Publication of AU2003250529A1 publication Critical patent/AU2003250529A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/02Blood transfusion apparatus
    • A61M1/0272Apparatus for treatment of blood or blood constituents prior to or for conservation, e.g. freezing, drying or centrifuging
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02Preservation of living parts
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02Preservation of living parts
    • A01N1/0205Chemical aspects
    • A01N1/021Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
    • A01N1/0226Physiologically active agents, i.e. substances affecting physiological processes of cells and tissue to be preserved, e.g. anti-oxidants or nutrients
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02Preservation of living parts
    • A01N1/0236Mechanical aspects
    • A01N1/0263Non-refrigerated containers specially adapted for transporting or storing living parts whilst preserving, e.g. cool boxes, blood bags or "straws" for cryopreservation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dentistry (AREA)
  • Environmental Sciences (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Anesthesiology (AREA)
  • Vascular Medicine (AREA)
  • Mechanical Engineering (AREA)
  • Biophysics (AREA)
  • Physiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
AU2003250529A 2003-06-20 2003-06-20 A FORMULATION AND A PROCESS FOR REDUCING THE DETERIORATION OF RBCs OF BLOOD DURING STORAGE WITH PARTICULAR REFERENCE TO DECREASE IN THE LEVEL OF 2,3 DIPHOSPHOGLYCERATE Abandoned AU2003250529A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IN2003/000226 WO2004112631A1 (fr) 2003-06-20 2003-06-20 Formulation et procede de reduction de la deterioration des globules rouges du sang lors du stockage, notamment en ce qui concerne la diminution du niveau de 2,3 diphosphoglycerate

Publications (1)

Publication Number Publication Date
AU2003250529A1 true AU2003250529A1 (en) 2005-01-04

Family

ID=33524008

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003250529A Abandoned AU2003250529A1 (en) 2003-06-20 2003-06-20 A FORMULATION AND A PROCESS FOR REDUCING THE DETERIORATION OF RBCs OF BLOOD DURING STORAGE WITH PARTICULAR REFERENCE TO DECREASE IN THE LEVEL OF 2,3 DIPHOSPHOGLYCERATE

Country Status (2)

Country Link
AU (1) AU2003250529A1 (fr)
WO (1) WO2004112631A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2503949A (en) * 2012-07-14 2014-01-15 Nobel Biocare Services Ag An agent for promoting osseointegration of implants
GB2503950A (en) * 2012-07-14 2014-01-15 Nobel Biocare Services Ag An agent for promoting osseointegration of bone substitute materials
GB2504679A (en) 2012-08-03 2014-02-12 Nobel Biocare Services Ag Bone substitute structure and material
JP6040307B2 (ja) * 2013-04-01 2016-12-07 テルモ株式会社 赤血球保存液、保存液収納容器、赤血球保存液の製造方法および血液バッグシステム
CA3129733A1 (fr) * 2019-03-15 2020-09-24 Junko TOMIZUKA Liquide de stockage pour cellules de mammifere

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3185108B2 (ja) * 1990-11-07 2001-07-09 バクスター、インターナショナル、インコーポレイテッド 赤血球貯蔵溶液

Also Published As

Publication number Publication date
WO2004112631A1 (fr) 2004-12-29

Similar Documents

Publication Publication Date Title
PL1702675T3 (pl) Sposób ciągłej multi-mikroenkapsulacji dla poprawy stabilności i dopuszczalnego czasu przechowywania składników biologicznie aktywnych
AU2003206760A1 (en) Anticholinergic agents, method for producing the same and use thereof as medicaments
EP1479649A4 (fr) Structure noyau-enveloppe a cavite maitrisee et structure comprenant la structure a noyau-enveloppe en tant que composant, et procede de preparation associe
AU2003212323A1 (en) Benzodiazepine-substituted piperidines for utilization in the treatment of cardiovascular diseases
PL369889A1 (en) Anticholinergic agents, method for producing the same and use thereof as medicaments
AU2003246159A1 (en) Nobonene-ester based addition polymer and method for preparing the same
AU2003222149A1 (en) High level expression of immunogenic proteins in the plastids of higher plants
EP1500645A4 (fr) Esters d'acides gras a chaine moyenne astaxanthine, leur procede de production et compositions renfermant ces esters
EP1577384A4 (fr) Plante a contenu proteique de graine reduit, procede de construction de ladite plante et son procede d'utilisation
AU2002254942A1 (en) Paracetamol solutions which are stable in storage and ready for infusion
EP1759582A4 (fr) Solution de conservation pour cellules, tissus et organes comprenant un sucre rare et procede de conservation faisant usage de celle-ci
WO2002004409A3 (fr) Agents neuroprotecteurs à base d'analogues de tétrahydrobenzothiazole
AU2003236521A1 (en) Methods of reducing hypoglycemic episodes in the treatment of diabetes mellitus
EP1765832B8 (fr) Nouveaux composes oxabispidine et leur utilisation dans le traitement des arythmies cardiaques
TWI319762B (en) 1,7,8-trifluoro-2-naphthol and manufacturing methods for liquid crystal compositions containing the same
AU2003243022A1 (en) 1,2,4-triazole derivative, method for preparing the same, and pharmaceutical composition containing the same
AU2003250529A1 (en) A FORMULATION AND A PROCESS FOR REDUCING THE DETERIORATION OF RBCs OF BLOOD DURING STORAGE WITH PARTICULAR REFERENCE TO DECREASE IN THE LEVEL OF 2,3 DIPHOSPHOGLYCERATE
IL174438A0 (en) Phenylacetic acid derivative, process for producing the same, and use
AU2003292665A1 (en) Flavorful cream excelling in emulsion stability and process for producing the same
PL362944A1 (en) Mixture of active compounds, application of the mixture, microbicide compound, method of preservation of technical materials and technical materials
AU2003252720A1 (en) Packaged container for ocular perfusion/washing solution and process for producing the same
AU2003215704A1 (en) Method of treating a part in order to alter at least one of the properties thereof
AU2003253248A1 (en) A formulation and a process for reducing the deterioration of blood with particular reference to decrease in the level of 2,3 diphosphoglycerate during storage
PT1532141E (pt) Derivados de 2-pirrolidin-2-il-[1,3,4]-oxadiazole e sua utilização como antidepressivos
AU2003269871A1 (en) Radiosensitizer composition containing n-acetylphytosphingosine analogs and n,n-dimethyl-phytosphingosine analogs as the active ingredients

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase